SEARCH RESULT

Total Matching Records found : 205

50% Indian smokers don’t know it can kill-Sanchita Sharma

Smoking kills, but most smokers still don’t know how. One in two Indian smokers isn’t aware that tobacco addiction can lead to stroke and 38% that it can cause heart disease.   These are some of the startling findings of a World Heart Federation report that will be released at the World Congress of Cardiology (WCC) in Dubai on Saturday. India is high on tobacco addiction. It has 138 million smokers and 28%...

More »

Western warnings-R Ramachandran

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...

More »

Alcohol consumption three times higher among youngsters watching Bollywood movies: Study-Kounteya Sinha

Bollywood has now been blamed for fuelling India's love for alcohol. Alcohol use in Bollywood movies is directly influencing the drinking habits of India's adolescents, according to a new study presented on Friday at the World Congress of Cardiology in Dubai. Overall 10% of the students (aged between 12-16 years) surveyed in the study had already tried alcohol. But students that had been most exposed to alcohol use in Bollywood movies...

More »

Patent to plunder -Amit Sengupta

India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...

More »

A welcome first -TK Rajalakshmi

Industry reacts with caution to the grant of a compulsory licence to Natco, but cancer patients welcome it and hope for many more. THE first compulsory licence (CL) issued by the Indian patent office, to the local drug manufacturer Natco Pharma Ltd to sell the generic version of Bayer AG's anti-cancer drug Nexavar, has led to varied reactions. The landmark decision has also raised concerns about the outcome of cases...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close